Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus acidophilus L-92 and Improved Atopic Dermatitis Symptoms

Research synthesisModerate evidenceLarge effect4 studies · 4 beneficial · 0 neutral · 0 harmful

Across 4 studies (2 randomized controlled trials and 2 reviews), all reported beneficial effects of Lactobacillus acidophilus L-92 on atopic dermatitis symptoms. The two RCTs both showed large, statistically significant improvements in SCORAD scores in Japanese adults (p=0.002) and children. The two reviews provide additional support, but the evidence base is small and all studies show positive results, raising concern for publication bias.

  • Studied populations: Adults and children with atopic dermatitis (Japanese populations studied)

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Evidence base is small (only 4 studies) — conclusions should be considered preliminary. No dose or treatment duration data were consistently reported across studies, limiting the ability to recommend a specific regimen.

Generated May 12, 2026
Doses used in studies
  • CFU/day: 1 (median 1, IQR 11) 1 study
4 of 4 papers
Back to top